Researchers found that a blood biomarker could help identify Alzheimer’s risk in cognitively healthy adults, though experts advise against routine screening.

Researchers argue that steatotic liver disease should be managed as an evolving trajectory rather than a static diagnosis to account for fluctuating metabolic and alcohol-related risks.